Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.11851/866
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSönmez, Alper-
dc.contributor.authorHaymana, Cem-
dc.contributor.authorBayram, Fahri-
dc.contributor.authorSalman, Serpil-
dc.contributor.authorDizdar, Oğuzhan Sıtkı-
dc.contributor.authorGürkan, Eren-
dc.contributor.authorÇarlıoğlu, Ayşe Kargılı-
dc.contributor.authorBarçın, Cem-
dc.contributor.authorSabuncu, Tevfik-
dc.contributor.authorSatman, İlhan-
dc.contributor.authorDemirbaş, Berrin-
dc.date.accessioned2019-03-28T10:51:41Z
dc.date.available2019-03-28T10:51:41Z
dc.date.issued2018-12
dc.identifier.citationSonmez, A., Haymana, C., Bayram, F., Salman, S., Dizdar, O. S., Gurkan, E., ... & Guldiken, S. (2018). Turkish nationwide survEy of glycemic and other Metabolic parameters of patients with Diabetes mellitus (TEMD study). Diabetes research and clinical practice, 146, 138-147.en_US
dc.identifier.urihttps://doi.org/10.1016/j.diabres.2018.09.010-
dc.identifier.urihttps://hdl.handle.net/20.500.11851/866-
dc.description.abstractAIMS: Turkey has the highest prevalence of diabetes in Europe. It is therefore essential to know the overall cardiovascular risk and reveal the predictors of metabolic control in Turkish adults with diabetes mellitus. METHODS: A nationwide, multicenter survey consecutively enrolled patients who were under follow up for at least a year. Optimal control was defined as HbA1c < 7%, home arterial blood pressure (ABP) < 135/85 mmHg, or LDL-C < 100 mg/dL. Achieving all parameters indicated triple metabolic control. RESULTS: HbA1c levels of patients (n = 5211) were 8.6 ± 1.9% (71 ± 22 mmol/mol) and 7.7 ± 1.7% (61 ± 19 mmol/mol), in Type 1 and Type 2 diabetes, respectively. Glycemic control was achieved in 15.3% and 40.2%, and triple metabolic control was achieved in 5.5% and 10.1%, respectively. Only 1.5% of patients met all the criteria of being non-obese, non-smoker, exercising, and under triple metabolic control. Low education level was a significant predictor of poor glycemic control in both groups. CONCLUSIONS: Few patients with Type 2, and even fewer with Type 1 diabetes have optimal metabolic control in Turkey. TEMD study will provide evidence-based information to policy makers to focus more on the quality and sustainability of diabetes care in order to reduce the national burden of the disease.en_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.ispartofDiabetes Research and Clinical Practiceen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectType 2 diabetesen_US
dc.subjectType 1 diabetesen_US
dc.subjectLDL-cholesterolen_US
dc.subjectHbA1cen_US
dc.subjectArterial blood pressureen_US
dc.titleTurkish Nationwide Survey of Glycemic and Other Metabolic Parameters of Patients With Diabetes Mellitus (temd Study)en_US
dc.typeArticleen_US
dc.departmentFaculties, School of Medicine, Department of Internal Medical Sciencesen_US
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümütr_TR
dc.identifier.volume146en_US
dc.identifier.startpage138en_US
dc.identifier.endpage147en_US
dc.identifier.wosWOS:000452704800016en_US
dc.institutionauthorÇarmıklı, Berrin Demirbaş-
dc.identifier.pmid30244051en_US
dc.identifier.doi10.1016/j.diabres.2018.09.010-
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
item.openairetypeArticle-
item.languageiso639-1en-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
Appears in Collections:Dahili Tıp Bilimleri Bölümü / Department of Internal Medical Sciences
PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection
Show simple item record



CORE Recommender

SCOPUSTM   
Citations

12
checked on Dec 21, 2024

WEB OF SCIENCETM
Citations

23
checked on Dec 21, 2024

Page view(s)

96
checked on Dec 23, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.